Abstract：Periodontitis
Introduction
Emdogain® (EMD) 1) is a material extracted from the tooth germ of juvenile swine that can generate acellular cementum and facilitate periodontal regeneration in patients with periodontitis characterized by marked alveolar bone resorption [2] [3] . Emdogain® or Emdogain® gel has been clinically used for more than a decade to produce marked regenerative effects [4] [5] [6] . The regeneration of alveolar bone after application of EMD can be observed by X-ray analysis. In addition, the molecular mechanisms underlying the action of EMD on the structural cells of periodontal tissue have been comprehensively investigated for about a decade to substantiate its regenerative effects [7] [8] [9] . Periodontal regenerative therapy with EMD is being established. The therapy is recognized as "advanced medicine" in Japan.
Because EMD is a biological material extracted from the tooth germ of juvenile swine, patients sometimes reject EMD treatment due to concerns about unknown pathogens. Currently, many patients still choose guided tissue regeneration (GTR) with a nonresorbable or resorbable membrane, an autogenous graft or a combination of these methods for periodontal regenerative therapy in Japan [10] [11] [12] . Therefore, to best utilize the clinical data obtained regarding the regenerative effects and postoperative stability of EMD, EMD-derived synthetic peptides should be developed. Traditional EMD (Emdogain®) was subcutaneously injected into the backs of rats to form eosinophilic corpuscles and chondroid tissue 13) demonstrated that the fragments contained the amino acid sequence, WYQNMIR. Database analysis demonstrated that the sequence corresponded to a swine amelogenin II precursor. A peptide based on the sequence was synthesized and subcutaneously inoculated into the backs of rats. Two weeks later, the peptide induced bone, cartilage and endochondral ossification, suggesting that it induced hard tissue formation 14) . Specifically, the peptide may function as a growth factor to induce cell differentiation for tissue engineering applications 15) . The activity of the peptide should therefore be investigated both in vitro and in vivo.
To investigate the functions of novel growth factors, their optimal concentrations should be determined in vitro and in vivo.
Various growth factors used for regenerative therapy, such as platelet-rich plasma (PRP), platelet-derived growth factor and basic fibroblast growth factor (b-FGF), have been investigated and applied clinically. Graziani et al. examined the effects of PRP on osteoblasts and fibroblasts, and demonstrated that the effects of PRP were dose-dependent and that increased doses were not necessarily effective for tissue regeneration 16) . Gamal et al. examined the effects of PDGF-BB on the adhesion of periodontal ligament fibroblasts obtained from a patient with periodontitis. PDGF-BB was most active at 50 ng/mL 17) . However, the effects remained the same at 50 ng/mL or above. Thus, 50 ng/mL was determined to be the optimal dose for treating periodontal wounds.
Takayama et al. demonstrated that the effects of b-FGF on human periodontal ligament cell proliferation were dose-dependent, and that b-FGF stimulated higher ALP activity at lower concentrations during differentiation of the cells into calcified tissue 18) . Thus, there may be optimal concentrations for the biological application of growth factors. In particular, in vitro studies demonstrate that the kinetics of growth factors vary according to the sources of cells.
In this study, we examined the effects of the novel synthetic peptide derived from EMD on human gingival epithelial cells 19) . The peptide was effective in suppressing the proliferation of epithelial tissue immediately after periodontal surgery until periodontal regeneration, and in facilitating postoperative wound healing. We previously reported that the peptide induced osteogenesis 20) and cementogenesis 21) in animal experiments using SD rats, and stimulated the differentiation of rat bone marrow cells into hard tissue in vitro. According to GTR principles, inhibition of both the growth of epithelial cells and the proliferation of mesenchymal stem cells are required in periodontal regeneration therapy to make space for a regenerative region and strong connective tissue adhesion, instead of long epithelial adhesion [22] [23] [24] [25] .
The optimal concentration of the novel 13) EMD-derived synthetic peptide remains unknown. Here, we used human periodontal ligament fibroblasts (HPdLF) as a model of mesenchymal stem cells to determine the optimal concentration of the peptide required to stimulate their proliferation, adhesion and migration. The effects of the optimal concentration of the peptide on hard tissue formation like cementum or alveolar bone were then examined.
Material and Methods

Cell culture
The HPdLF cells used in this study were purchased from Lonza. 
Peptide synthesis
The oligopeptide, WYQNMIR, derived from Emdogain® was prepared by traditional solid-phase peptide synthesis in conjunction with "tea-bag" methodology using Boc/benzyl-based chemistry. Briefly, chondrogenesis was observed 7 days after injection of 30 mg of EMD dissolved in 1 mL of propylene glycol into the backs of rats, with numerous eosinophilic round bodies (ERBs) around the formed cartilage tissue. ERBs were examined in pathological sections and analyzed biochemically. ERBs were pathologically found not to contain polysaccharide, amyloid or hemosiderin. Biochemical analysis of ERBs revealed a 40-kd band that did not contain EMD. Matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and database analysis of ERBs identified a seven-amino-acid sequence encoded by amelogenin-exon 5.
Cell proliferation assay
HPdLF cells were harvested and plated at a density of 4×10 4 cells/well in 96-well microplates (Falcon). After 24 hours, the medium was replaced with medium containing the synthetic oligopeptide at concentrations of 0, 5, 20, 100, 200 or 500 ng/ml. After washing the microplates with PBS, cell proliferation/viability was determined using the CellTiter-Blue™ Cell Viability Assay Kit (Promega, Madison, WI, USA) after 1, 3, 6 and 72 h of incubation according to manufacturer's instructions. Initially, the CellTiter-Blue™ reagent was diluted 6 times in PBS. Following aspiration of the medium and washing with PBS, 100 l of reagent were added to each well and the plates were incubated for 1 h at 37°C in a humidified 5% CO 2 /95% air atmosphere. Fluorescence Yoichiro Taguchi et al.: Hard Tissue Formation by HPdLFs with EMD Derived Peptide intensity (excitation 560nm, emission 590nm) was measured using a multi-microtiter reader (SpectraMax® M5, Molecular Device Inc, Sunnyvale, CA, USA).
Cell adhesion assay
Cell adhesion assays were performed as described previously. 
Cell chemotaxis assay
To investigate the chemotaxis of HPdLF cells, a modified
Boyden chamber assay was performed using a 24-well microchemotaxis chamber (Fluoroblock Insert system; Falcon) The contents of the upper and lower wells were separated by a 3.0 m pore size HTS FluoroBlock™ Insert (Falcon). Cell chemotaxis was observed for 1 h, 3 h and 8 h at 37°C in a humidified 5% CO 2 /95% air atmosphere. HPdLF cells that had passed through the filter into the lower chamber were evaluated on a fluorescence plate reader (SpectraMax® M5) with an excitation wavelength of 485 nm and an emission wavelength of 535 nm.
Measurement of alkaline phosphatase activity
The optimal peptide concentration was determined from the results of the cell proliferation, adhesion and chemotaxis assays. In the test group, HPdLF cells were cultured in the presence of the optimal concentration of the oligopeptide, osteogenic supplements (10 mM -glycerophosphate (Wako), 80 mg/mL of ascorbic acid (Nacalai Tesque Inc, Kyoto, Japan), and 10 nM dexamethasone (Nacalai Tesque Inc). In the control group, cells were cultured in medium without the oligopeptide. After 7 and 14 days of culture, cells were washed with PBS, lysed with 200 L of 0.2% Triton X-100 (Sigma, St. Louis, MO, USA), and the lysate was transferred to a microcentrifuge tube containing a 5 mm hardened steel ball. The tubes were agitated on a shaker (Mixer Mill Type MM 301, Retsh Gmbh & Co., Haan, Germany) at 29 Hz for 20 s to homogenize the samples. ALP activity was measured using the Alkaline Phosphatase Luminometric ELISA Kit (Sigma) according to the manufacturer's protocol. The reaction was terminated by adding 3 N NaOH to a final concentration of 0.5 N NaOH, and p-nitrophenol production was measured by absorbance at 405 nm using a microplate reader. DNA content was measured using the PicoGreen dsDNA Assay Kit according to the manufacturer's protocol. To normalize ALP activity, the amount of ALP was normalized to the amount of DNA in the cell lysate.
Measurement of osteocalcin levels
The OCN levels in the cell culture supernatants were measured using a commercially available ELISA Kit (A Gla-Type Osteocalcin EIA Kit (Takara Bio Inc.,Shiga,Japan).according to the manufacturer's instructions. This kit is specific for human osteocalcin (OCN) and can measure its levels directly in cell culture supernatants after 28 days of culture.
Mineralization
Calcium deposited in the extracellular matrix was measured after dissolution with 10% formic acid. The amount of calcium was quantified using a Calcium E-test Kit (Wako). After 14 days of culture, 1 mL of Calcium E-Test reagent and 2 mL of kit buffer were added to 50 mL of collected medium, and the absorbance of the reaction products was measured at 610 nm using a microplate reader. The concentration of calcium ions was calculated from the absorbance value relative to a standard curve.
Statistical analysis
Data are presented as mean ± standard deviation, and all data were subjected to one-way analysis of variance (ANOVA). In all assays, P-values less than 0.05 were considered significant.
Results
Effect of the Emdogain®-derived synthetic oligopeptide on the proliferation of HPdLF cells
The effect of the synthetic oligopeptide on the proliferation of HPdLF cells as measured by MTS assay is shown in Fig. 1 . After incubation with the peptide for 1 and 3 hours, the fluorescence intensity was highest in the 100 ng/ml oligopeptide group. After incubation for 6 hour, there was no significant difference in the fluorescence intensity between the 100 ng/ml oligopeptide group and the group incubated in medium without oligopeptide. After 6 hours of incubation, the fluorescence intensities in the 20 ng/ml and 100 ng/ml oligopeptide groups were significantly higher than in the other groups. Fig. 2 shows that cell adhesion was highest in the group incubated with 100 ng/ml of oligopeptide at 30 s and 3 h after cell plating. Cell adhesion in the 20 ng/ml and 100 ng/ml oligopeptide groups was significantly higher than in the other groups at 2 h after cell plating. After incubation for 1 hour, there was no significant difference in cell adhesion between the 100 ng/ml oligopeptide group and the group incubated in medium without oligopeptide. (medium containing FBS) tha in the negative control group (medium not containing FBS) at all time points. After 1, 4, 6 and 8 hours of incubation, chemotaxis in the 100 ng/ml oligopeptide group was significantly higher than in the group incubated in medium without oligopeptide.
Effect of the Emdogain®-derived synthetic oligopeptide on the adhesion of HPdLF cells
Effect of the Emdogain®-derived synthetic oligopeptide on the chemotaxis of HPdLF cells
ALP activity
100 ng/ml of oligopeptide was determined as the optimal concentration for differentiation studies. Cell differentiation was assessed by measuring the activity of the differentiation marker, ALP, in the test and control groups after incubation with the oligopeptide for 21 days. At this point, ALP activity was significantly higher in the cells of the test group compared with the control group (Fig. 4) .
Osteocalcin Production
Fig .5 shows the production of OCN in the test and control groups after incubation with the oligopeptide (100 ng/ml) for 28 days. The presence of OCN in the supernatant of the test group was significantly higher than in the control group. Mineralization Fig. 6 shows calcium deposition in the extracellular matrix of HPdLF cells in the test and control groups after incubation with the oligopeptide (100 ng/ml) for 28 days. The deposition of calcium is cumulative such that the levels measured increase with exposure time. Significantly more calcium was deposited by the cells in the test group than by cells in the control group after 28 days.
Discussion
In this study, we examined the effects of an Emdogain®-derived synthetic peptide on the proliferation and differentiation of HPdLF cells as a model of mesenchymal cells. First, HPdLF cell proliferation, adhesion and migration were examined at five peptide concentrations to determine the optimal concentration of the peptide. Next, the differentiation of HPdLF cells into hard tissue after stimulation with the optimal concentration of peptide was examined. Because stimulation with 100 ng/mL of peptide resulted in the highest proliferation, adhesion and migration activities of the HPdLF cells, 100 ng/mL was determined to be the optimal concentration for the differentiation studies. Incubation of HPdLF cells with 100 ng/mL of peptide significantly increased ALP activity after 14 and 21 days, osteocalcin production in the culture supernatant after 21 days, and intracellular calcium deposition levels after 28 days, in the experimental group compared with the control group.
Periodontal growth and regeneration require novel periodontal tissue formation, including cementum, alveolar bone and periodontal ligament, due to cell growth in intraosseous defects after inflammatory tissue dissection. The most rapidly growing tissue during early wound healing after periodontal surgery is gingival epithelium, which forms a gingival full-thickness flap.
Epithelial cells proliferate to facilitate apical growth deep into the epithelial tissue and form long epithelial junctional adhesions parallel to the tooth roots. However, this healing does not promote new connective tissue and precludes periodontal regeneration 26) .
Kramer suggested that the suppression of deep epithelial proliferation prior to the formation of new periodontal tissue is required to achieve regeneration during early healing 27) . Because regeneration materials such as Emdogain®, PRP and PDGF act as growth factors to stimulate various cells and induce regeneration 15) , we suggest that the Emdogain®-derived synthetic peptide also functions as a growth factor. Early proliferation and differentiation of mesenchymal cells, i.e., periodontal ligament cells or bone marrow mesenchymal cells, is required to repair periodontal tissue defects 15) . In particular, immediately after application of regeneration materials, an increased number of cells are required to suppress deep epithelial proliferation and the formation of long epithelial adhesions rather than to differentiate into hard tissue. Thus, we hypothesized that cell proliferation, adhesion and Figure 1 . Effect of the synthetic oligopeptide on the proliferation of HPdLF cells measured by MTS assay. After 1 and 3 hours of incubation with the oligopeptide, the fluorescence intensity in the 100 ng/ml oligopeptide group was higher than in the groups treated with the other concentrations of the oligopeptide. After 6 hours of incubation, there was no significant difference in the fluorescence intensity between the 100 ng/ml oligopeptide group and the group incubated in medium without oligopeptide. After 72 hours, the fluorescence intensities in the groups incubated with 20 ng/ml and 100 ng/ml of oligopeptide were significantly higher than in the other groups(*: P<0.05).
379 migration should be assayed to determine the optimal concentration of the peptide for use in differentiation studies.
Melcher suggested that the main goal of periodontal regenerative therapy is to induce connective tissue adhesion, and cell adhesion to tooth roots plays an important role during wound healing after periodontal surgery 28) . We regard adhesion of the factor to mediate this adhesion 29, 30) . 33) . This is caused by the fact that periodontal ligament cells consist of a heterogeneous cell population including undifferentiated mesenchymal cells. Periodontal ligament cells have been suggested to differentiate into various different cell types. The synthetic Emdogain® peptide promoted the growth of periodontal ligament cells at each time point tested, with a concentration of 100 ng/ml stimulating the highest rate of proliferation. It is thought that the proliferation rate of HPdLF cells is high prior to their differentiation into cementoblasts and osteoblasts 20, 21) . Also, our results agree with the report by Hoang et al., which showed that HPdLF cells proliferate after the formation of a cement-like hard tissue by Emdogain® 34) .
Rincon et al. suggested that periodontal ligament cell migration, as well as adhesion and proliferation, is increased by Emdogain® 29, 30) . Because alimentation to the regenerative area is necessary for enabling periodontal tissue to regenerate, the activity of Emdogain® as a regenerative material is strongly associated with Figure 2 . Effect of the EMD-derived synthetic oligopeptide on the adhesion of HPdLF cells after 30 seconds, 1, 2 and 3 hours of culture. Cell adhesion in the groups incubated with 20 ng/ml and 100 ng/ml of oligopeptide was significantly higher than in the other groups 2 h after plating HPdLF cells(*: P<0.05). There was no significant difference between the group incubated with 100 ng/ml oligopeptide and the group incubated in medium without oligopeptide after 1 hour. suggest that the Emdogain®-derived synthetic peptide initiates cell attachment, which then leads to cell proliferation and chemotaxis. The potential for hard tissue formation was examined at the optimal concentration of 100 ng/ml, which was determined from the results of the HPdLF cell attachment, proliferation and chemotaxis experiments.
Many reports have been published on the differentiation of HPdLF cells into bone. Our results suggest that Emdogain® contributes to increased ALP activity, but Hoang et al. reported that HPdLF cells exhibit multipotent differentiation similar to mesenchymal stem cells and may form cementum 34) . Nagano et al. reported that HPdLF cells can differentiate into osteoblastic cells 32, 35 -37) . The Emdogain®-derived synthetic peptide promoted increased ALP activity in this study. Additional studies will be necessary in future, but our results suggest that this peptide contributes to the formation of cementum as reported by Noguchi et al., and this observation agrees with the report of Hoang et. al 34) . In this study, OCN production and calcium deposition were increased by the Emdogain®-derived synthetic peptide. Many studies have shown that Emdogain®, which is extracted from pig juvenile enamel, leads to bone and cementum formation 32, 35 -37) . Alveolar bone and cementum are both required for periodontal regeneration, and are essential for the maintenance of hard tissue morphology 1) . Nagano et al. reported that the expression of genes encoding ALP, osteopontin, osteocalcin, BSP and cementum is increased in HPdLF cells, suggesting that these cells differentiate into osteoblastic cells or cementum 32) . The results from studies by Nagano et al. 32) and Monique et al. 29, 30) , which showed that Emdogain® increases OCN production and calcium deposition, suggest that calcification is accelerated by Emdogain®. The
Emdogain®-derived synthetic peptide used in this study also accelerated calcification, suggesting that this peptide makes bone or cementum.
This study suggests that an Emdogain®-derived synthetic peptide facilitated hard tissue formation during periodontal . Calcium deposition after 28 days in the test and control groups was estimated. Ca deposition is cumulative and increases with incubation time. Significantly more calcium was deposited by cells in the test group than by cells in the control group after 28 days(*: P<0.05).
